Sign in
4

Changes in Ownership

Vanda Pharmaceuticals Inc. Filed Acc 0000950170-24-027259

SVP, Chief Marketing Officer sold 16,727 shares at an average $4.30 ($71,921)

From the SEC's structured data for this filing

Trades in this filing

Wijkstrom Joakim · SVP, Chief Marketing Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2024-03-04 Sale : show line 1 in the form −7,498 $4.41 $33,091 139,018 D
2024-03-05 Sale : show line 2 in the form −9,229 $4.21 $38,830 129,789 D
Open-market sales · 16,727 sh · avg $4.30 · $71,921
Loading xslF345X05/ownership.xml…